ARTICLE | Clinical News

Flubok regulatory update

November 17, 2014 8:00 AM UTC

Protein Sciences said FDA granted accelerated approval to an sBLA for Flublok seasonal influenza vaccine to prevent seasonal influenza infection in adults ages >=50 years. Flubok was approved in adults ages 18-49 years. The trivalent seasonal influenza vaccine is made with recombinant hemagglutinin antigens purified from cultured insect cells. ...